Navigation Links
Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor

a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. The Company seeks to improve the performance and safety of existing treatments by addressing significant problems such as drug metabolism, bioavailability, excessive toxicity and treatment resistance. More information can be found on the Company's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual results for our CoFactor studies to differ materially include, but are not limited to: the validity of research results; unexpected adverse side effects or inadequate therapeutic efficacy of CoFactor(R) or Adventrx's other product candidates; the risk that preclinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical and clinical data suggests or as otherwise anticipated; uncertainties inherent in the drug development process; the timing and success of clinical trials; the receipt of necessary approvals from the FDA and other regulatory agencies; and other risks and uncertainties more fully described in ADVENTRX's press releases and public filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov. ADVENTRX does not intend to update any forward-looking st
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/29/2014)... Ohio and CAMBRIDGE, Mass. ... Specialty Solutions and KEW Group, Inc. (KEW), a ... agreement for the two companies to make KEW,s ... oncology customers. KEW is a privately ... revolutionizing cancer care by empowering all oncologists to ...
(Date:9/29/2014)... , Sept. 29, 2014 Galmed Pharmaceuticals ... clinical-stage biopharmaceutical company focused on the development and ... treatment of liver diseases and cholesterol gallstones, announced ... accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar ... has been cleared by the U.S. Food and ...
(Date:9/29/2014)... , Sept. 29, 2014 Avanir Pharmaceuticals, ... closing of its previously announced public offering of 20,930,000 ... to the underwriters, full exercise of their option to ... of $11.00 per share, before underwriting discounts. J.P. Morgan, ... joint book-running managers for the offering. Piper Jaffray ...
Breaking Medicine Technology:Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists 2Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists 3Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists 4Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 3
... Inc., a leading provider of healthcare IT and medical billing ... prestigious 2010 Inc. 5000 list, a compendium of the most ... order to qualify for the Inc. 5000, companies such as ... exemplary four-year growth. Founded in 2005, this was the first ...
... Store announced today it has selected an integrated Omnicom team ... revamping its roster of agencies to include a new team ... and proven expertise in branding and direct response. The Omnicom ... includes Porter Novelli, Javelin Marketing Group and AdelphiEden.   ...
Cached Medicine Technology:ITelagen Named to Prestigious 2010 Inc. 5000 List of Fastest-Growing Companies 2The SCOOTER Store Partners With Branding Leader 2
(Date:9/30/2014)... (PRWEB) September 30, 2014 Barbara Williamson ... her amazing memoir "An Extraordinary Life: Love, Sex ... β€œthe messiah of sex,” of the highly successful and ... 1960s and early β€˜70s, the couple started what became ... The clothing-optional, alternate-lifestyle Sandstone Retreat was outrageously popular, with ...
(Date:9/30/2014)... In a move that will ... capture and management functions for sponsors, Synergy Research ... (EDC) system. ClinCapture offers advanced out-of-the-box features that ... clinical trial data and avoid errors and duplications. ... the leading clinical research organization in the Russian ...
(Date:9/30/2014)... 2014 Computer Resources of America, ... based in New York City, has been awarded ... to transform, manage, and support the IT environment ... a leading provider of innovative services that enable ... The contract will cover the four NY-metro ...
(Date:9/30/2014)... September 30, 2014 Miraca Life Sciences ... present eight research posters at the annual meeting of ... will hold its Annual Scientific Meeting and Postgraduate Course ... hall, staff from Miraca Life Sciences will be at ... Clinical Case Challenge. , The research posters for ACG ...
(Date:9/30/2014)... Bibliomotion is proud to announce the release of ... Age by Frank Guglielmo and Sudhanshu Palsule ... apply their leadership coaching experience to introduce Social Leadership – ... behaviors that leaders must adopt in order to thrive in ... a review of The Social Leader in Dialogue Reviews. , ...
Breaking Medicine News(10 mins):Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 3Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:Miraca Life Sciences Research Institute to Present Eight GI Pathology Research Studies at Annual Meeting of American College of Gastroenterologists 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6
... Will build upon Research, Care, Advocacy and Education Programs ... YORK, Jan. 29 The Trustees of the Huntington,s ... that Louise Vetter, currently CEO of the American Lung ... Chief Executive Officer, Monday, March 16. In her nine ...
... Mice whose fat cells were allowed to grow larger than fat ... diet, researchers at UT Southwestern Medical Center found in a new ... called collagen VI, which normally surrounds fat cells and limits how ... The findings appear online and in a future edition of ...
... (RA) remains unclear, bioactive proteins known as cytokines, particularly ... a major role in the disease by contributing to ... cytokine, has been thought to be critical for a ... deliver oxygen and nutrients to fetus. A new study ...
... North State Bancorp (OTC,Bulletin Board: NSBC) (the "Company"), ... of $687.6 million as of December 31, 2008,compared to ... an increase,of $140.1 million or 25.6%. , ... December 31, 2008 were $612.7,million and total loans were ...
... babies have complications, without ill effects, study finds , , THURSDAY, ... steroids to babies still in the womb can reduce their ... their growth the way multiple courses can, new research shows. ... of those given a second dose of steroids in utero ...
... Second Annual "For All the Ways You Care" ... of CaregivingWOONSOCKET, R.I., Jan. 29 CVS/pharmacy, the ... annual "For All the Ways You Care" contest ... http://www.newscom.com/cgi-bin/prnh/20090129/NE64371LOGO )CVS/pharmacy invites caregivers and ...
Cached Medicine News:Health News:Louise Vetter joins Huntington's Disease Society of America as new CEO 2Health News:Louise Vetter joins Huntington's Disease Society of America as new CEO 3Health News:UT Southwestern researchers identify protein that may explain 'healthy' obesity 2Health News:Process found to play role in rheumatoid arthritis could lead to new treatment 2Health News:North State Bancorp Reports Profitable 2008 2Health News:North State Bancorp Reports Profitable 2008 3Health News:North State Bancorp Reports Profitable 2008 4Health News:North State Bancorp Reports Profitable 2008 5Health News:North State Bancorp Reports Profitable 2008 6Health News:Additional Steroid Dose May Help Preemies 2Health News:Additional Steroid Dose May Help Preemies 3Health News:CVS/pharmacy Announces National Contest for Stories of Extraordinary Caregiving 2Health News:CVS/pharmacy Announces National Contest for Stories of Extraordinary Caregiving 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: